Poland· PL-100463322
Xevudy
A sotrovimab product containing sotrovimabum, registered in Poland by GlaxoSmithKline Trading Services Limited. The same ATC class is registered in 7 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Sotrovimab is registered in 7 of 19 countries.
Countries holding a registration under ATC J06BD05 (sotrovimab), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Sotrovimab · ATC J06BD05
7 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Franceprice
- Polandprice
- Spainprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Sotrovimabum
- Manufacturer
- GlaxoSmithKline Trading Services Limited
- Country
- Poland (PL)
- ATC code
- J06BD05
- ATC class
- Sotrovimab
- Defined daily dose
- 0.5 g, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991474980
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sotrovimab in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumXevudy 500 mgGlaxoSmithKline Trading Services
- DenmarkXevudyGlaxoSmithKline Trading Services Limited
- FinlandXevudyGlaxoSmithKline Trading Services Limited
- United KingdomSotrovimab 500mg/8ml solution for infusion vialsGlaxoSmithKline UK Ltd
- SpainXEVUDY 500 MG CONCENTRADO PARA SOLUCION PARA PERFUSIONGlaxosmithkline Trading Services Limited
- FranceXEVUDY 500 mg, solution à diluer pour perfusionGLAXOSMITHKLINE TRADING SERVICES (IRLANDE)
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/71afdd5a-f9a4-41ab-9978-445ca7c948b0 GET /v1/drugs/71afdd5a-f9a4-41ab-9978-445ca7c948b0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Koncentrat do sporządzania roztworu do infuzji",
"source": "urpl",
"strength": "500 mg",
"packaging": "05909991474980 ¦ Rp ¦ EU/1/21/1562/001 ¦ 143375\n1 fiol.",
"substance": "Sotrovimabum 500 mg",
"common_name": "Sotrovimabum",
"pl_product_id": "100463322",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about sotrovimab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.